Adare Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADARE PHARMS INC, and what generic and branded alternatives to ADARE PHARMS INC drugs are available?
ADARE PHARMS INC has four approved drugs.
Drugs and US Patents for Adare Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adare Pharms Inc | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078703-003 | Jul 15, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adare Pharms Inc | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078703-002 | Jul 15, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adare Pharms Inc | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 076368-002 | Jun 5, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adare Pharms Inc | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 076368-001 | Aug 18, 2004 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adare Pharms Inc | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210279-001 | Oct 9, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Adare Pharms Inc | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 078703-001 | Jul 15, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.